US2005089552A1PendingUtilityA1

Silk fibroin fiber bundles for matrices in tissue engineering

63
Assignee: TUFTS COLLEGEPriority: Nov 16, 2001Filed: Nov 16, 2004Published: Apr 28, 2005
Est. expiryNov 16, 2021(expired)· nominal 20-yr term from priority
A61P 9/00A61L 2430/10C12N 2533/50A61L 27/3834A61K 9/70Y10T442/2566C07K 14/43518A61K 35/12A61F 2/00A61L 27/3895Y10T428/298Y10T428/249921A61L 27/3821A61L 27/3662A61L 27/48C12N 5/066A61L 27/386A61P 21/00A61P 19/00A61L 27/3608A61F 2/08C12N 5/0663A61L 27/3804A61L 27/227A61K 35/28A61P 19/04A61K 38/17
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a novel silk-fiber-based matrix having a wire-rope geometry for use in producing a ligament or tendon, particularly an anterior cruciate ligament, ex vivo for implantation into a recipient in need thereof. The invention further provides the novel silk-fiber-based matrix which is seeded with pluripotent cells that proliferate and differentiate on the matrix to form a ligament or tendon ex vivo. Also disclosed is a bioengineered ligament comprising the silk-fiber-based matrix seeded with pluripotent cells that proliferate and differentiate on the matrix to form the ligament or tendon. A method for producing a ligament or tendon ex vivo comprising the novel silk-fiber-based matrix is also disclosed.

Claims

exact text as granted — not AI-modified
1 . A fiber construct comprising sericin-extracted silkworm fibroin fibers, wherein the fibers have a diameter of about 20 to about 40 μm and an average ultimate tensile strength of at least about 0.67 N/fiber.  
     
     
         2 . The fiber construct of  claim 1 , wherein the fibers are organized in parallel.  
     
     
         3 . The fiber construct of  claim 1 , wherein the fibers are organized in a helical, wire rope, twisted, braided, mesh-like or cabled geometry.  
     
     
         4 . The fiber construct of  claim 1 , wherein the fibers comprise a coating and/or surface modification that promotes cellular attachment and/or tissue differentiation and proliferation thereon.  
     
     
         5 . The fiber construct of  claim 4 , wherein said coating and/or surface modification comprises an arginine-glycine-aspartate (RGD) peptide.  
     
     
         6 . The fiber construct of  claim 4 , wherein said coating and/or surface modification comprises a growth factor.  
     
     
         7 . The fiber construct of  claim 1 , wherein the construct comprises a group of at least one to about 1300 fibroin fibers.  
     
     
         8 . The fiber construct of  claim 7 , wherein the construct further comprises at least two groups forming a bundle.  
     
     
         9 . The fiber construct of  claim 8 , wherein the construct further comprises at least two bundles forming a strand.  
     
     
         10 . The fiber construct of  claim 9 , wherein the construct further comprises at least two strands forming a cord.  
     
     
         11 . The fiber construct of  claim 7 , wherein the group comprises fibroin fibers organized in a parallel, helical, wire rope, twisted, braided, mesh-like or cabled geometry.  
     
     
         12 . The fiber construct of  claim 8 , wherein the bundle comprises groups organized in a parallel, helical, wire rope, twisted, braided, mesh-like or cabled geometry.  
     
     
         13 . The fiber construct of  claim 9 , wherein the strand comprises bundles organized in a parallel, helical, wire rope, twisted, braided, mesh-like or cabled geometry.  
     
     
         14 . The fiber construct of  claim 10 , wherein the cord comprises strands organized in a parallel, helical, wire rope, twisted, braided, mesh-like or cabled geometry.  
     
     
         15 . The fiber construct of  claim 1 , wherein the construct has an average ultimate tensile strength of at least about 6.67 N.  
     
     
         16 . The fiber construct of  claim 1 , further comprising cells.  
     
     
         17 . The fiber construct of  claim 16 , wherein the cells are selected from the group consisting of stem cells, muscle cells, bone marrow stromal cells, pluripotent cells, or fibroblast cells.  
     
     
         18 . A method for producing a sericin-extracted silk-fibroin fiber construct comprising: contacting at least one silkworm fibroin fiber with an aqueous solution of Na 2 Co 3  and detergent to extract sericin from the fiber.  
     
     
         19 . A method for producing a sericin-extracted silk-fibroin fiber construct comprising: 
 a. arranging at least 2 silkworm fibroin fibers to form a group; and    b. contacting the group with an aqueous solution of Na 2 Co 3  and detergent to extract sericin from the fibers.    
     
     
         20 . A method for producing a sericin-extracted silk-fibroin fiber construct comprising: 
 a. arranging at least 2 groups of silkworm fibroin fibers to form a bundle; and    b. contacting the bundle with an aqueous solution of Na2Co3 and detergent to extract sericin from the fibers.    
     
     
         21 . A method for producing a sericin-extracted silk-fibroin fiber construct comprising: 
 a. arranging at least 2 bundles of silkworm fibroin fibers to form a strand; and    b. contacting the strand with an aqueous solution of Na2Co3 and detergent to extract sericin from the fibers.    
     
     
         22 . A method for producing a sericin-extracted silk-fibroin fiber construct comprising: 
 a. arranging at least 2 strands of silkworm fibroin fibers to form a cord; and    b. contacting the cord with an aqueous solution of Na2Co3 and detergent to extract sericin from the fibers.    
     
     
         23 . The method as in one of claims  18 - 22 , wherein the sericin is extracted at a temperature no greater than about 90° C.  
     
     
         24 . The method as in one of claims  18 - 22 , further comprising the step of coating the fibroin fibers with a coating and/or surface modifier that promotes cellular attachment and/or tissue proliferation on the fibers.  
     
     
         25 . The method of  claim 24 , wherein said coating and/or surface modifier comprises an arginine-glycine-aspartate (RGD) peptide.  
     
     
         26 . The method of  claim 24 , wherein said coating and/or surface modifier comprises a growth factor.  
     
     
         27 . The method of  claim 19 , wherein said group comprises up to 1300 fibroin fibers.  
     
     
         28 . The method of  claim 18 , further comprising the step of placing the fiber in a twisted, helical, braided, mesh-like or cabled geometry.  
     
     
         29 . The method of  claim 19 , wherein the fibers are organized in a parallel, helical, wire rope, twisted, braided, mesh-like or cabled geometry.  
     
     
         30 . The method of  claim 20 , wherein the groups are organized in a parallel, helical, wire rope, twisted, braided, mesh-like or cabled geometry forming a bundle.  
     
     
         31 . The method of  claim 21 , wherein the bundles are organized in a parallel, helical, wire rope, twisted, braided, mesh-like or cabled geometry forming a strand.  
     
     
         32 . The method of  claim 22 , wherein the strands are organized in a in parallel, helical, wire rope, twisted, braided, mesh-like or cabled geometry forming a cord.  
     
     
         33 . The method as in any of claims  18 - 22 , further comprising: 
 a. contacting the construct with cells; and    b. culturing the construct under conditions suitable for cell growth and regeneration.    
     
     
         34 . The method of  claim 33 , wherein the cells are stem cells, muscle cells, bone marrow stromal cells, pluripotent cells, or fibroblast cells.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.